Clinical Trial Update: Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of motexafin gadolinium combined with chemotherapy and radiation for advanced head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Xcytrin (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Head and Neck Cancer, Oropharynx Cancer | Phase 1 | Status: TERMINATED